Delivery Order SPE2DR25D3103-SPE2DR26F0B4V

<p>The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on February 4, 2026, for Benlysta 200 mg/ml auto-injector with a ceiling value of $3,486.67 and an ultimate completion date of February 26, 2026.</p> <p>Place of performance is Conshohocken, PA. The order is firm fixed price with no set-aside applied.</p>

<p>The Defense Logistics Agency issued a $6,973.34 delivery order to Amerisourcebergen Drug Corp on February 5, 2026, for Benlysta 200 mg/mL autoinjector pharmaceutical product with an ultimate completion date of February 27, 2026.</p> <p>Place of performance is Conshohocken, PA. The order is issued under firm fixed pricing with no set-aside.</p>

<p>The Defense Logistics Agency issued a $3,486.67 delivery order to Amerisourcebergen Drug Corp on February 5, 2026, for Benlysta 200 mg/ml autoinjector with an ultimate completion date of February 27, 2026.</p> <p>Place of performance is Conshohocken, PA. The order is firm fixed price with no set-aside applied.</p>

The Defense Logistics Agency awarded a $6,973.34 firm fixed-price delivery order to Amerisourcebergen Drug Corp on January 29, 2026, for the supply of Benlysta 200 mg/ml auto-injector, with performance completion scheduled for February 20, 2026. This non-competitive delivery order was issued to the Conshohocken, Pennsylvania-based pharmaceutical distributor as a child entity under its parent company, Cencora, Inc. (formerly Amerisourcebergen). The delivery will be performed at the contractor's...

The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Benlysta 200 mg/ml auto-injector units with a contract ceiling value of $6,165.34. This is a firm fixed-price delivery order with an ultimate completion date of September 2, 2025, and represents a non-set-aside competitive award. The work will be performed at AmerisourceBergen's Conshohocken, Pennsylvania location. This delivery order is issued under AmerisourceBergen Drug...

The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on October 16, 2025, for the supply of Benlysta 200 mg/mL auto-injector medication. This firm fixed-price delivery order, valued at $12,330.68, is scheduled for completion by November 6, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award was made through competitive procurement with no set-aside designation, reflecting...

The Defense Logistics Agency awarded a delivery order valued at $3,486.67 to AmerisourceBergen Drug Corp for the supply of Benlysta 200 mg/ml auto-injectors, with a completion deadline of January 26, 2026. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded on January 2, 2026. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...

The Defense Logistics Agency awarded a delivery order valued at $12,981.42 to AmerisourceBergen Drug Corp for the supply of Benlysta 200 mg/ml auto-injectors. The contract, issued on November 20, 2025, with an ultimate completion date of December 12, 2025, represents a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, fulfilled this order under a competitive procurement process, demonstrating its capability to...

The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 26, 2026, for the supply of Benlysta 200 mg/mL auto-injector units, with a contract ceiling value of $3,486.67 and an ultimate completion date of February 17, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation, reflecting the vendor's demonstrated capability to meet federal pharmaceutical procurement requirements through open competition. The contract is...

The Defense Logistics Agency awarded a delivery order valued at $12,994.64 to AmerisourceBergen Drug Corp for the supply of Benlysta 200 mg/ml auto-injector on November 18, 2025, with completion scheduled by December 10, 2025. This firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Benlysta is a prescription biologic medication used primarily in the treatment of systemic lupus erythematosus,...